Sernova Biotherapeutics (OTCMKTS:SEOVF) Announces Quarterly Earnings Results

Sernova Biotherapeutics (OTCMKTS:SEOVF) released its earnings results on Friday. The company reported ($0.01) earnings per share for the quarter, Zacks reports.

Sernova Biotherapeutics Stock Down 0.1%

SEOVF opened at $0.09 on Friday. The firm has a market capitalization of $31.37 million, a P/E ratio of -2.37 and a beta of 1.08. The stock’s 50 day moving average price is $0.11 and its two-hundred day moving average price is $0.12. Sernova Biotherapeutics has a 12-month low of $0.09 and a 12-month high of $0.18.

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.